Krista La Perle

3.0k total citations · 2 hit papers
29 papers, 2.2k citations indexed

About

Krista La Perle is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Krista La Perle has authored 29 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Immunology. Recurrent topics in Krista La Perle's work include Cancer-related Molecular Pathways (4 papers), CAR-T cell therapy research (3 papers) and Thyroid Cancer Diagnosis and Treatment (3 papers). Krista La Perle is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), CAR-T cell therapy research (3 papers) and Thyroid Cancer Diagnosis and Treatment (3 papers). Krista La Perle collaborates with scholars based in United States, Italy and Canada. Krista La Perle's co-authors include Steven M. Larson, Michel Sadelain, Renier J. Brentjens, Raymond Yeh, Yan Nikhamin, Elmer Santos, Maiko Matsushita, Alfonso Quintás‐Cardama, Lianbo Yu and Michael A. Caligiuri and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Krista La Perle

27 papers receiving 2.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver

2012 623 citations Shu‐Hao Hsu, Bo Wang et al. Journal of Clinical Investigation profile →
Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells

2017 447 citations Krista La Perle et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Krista La Perle	1.3k	737	526	379	257	29	2.2k
Mihai Gagea	1.6k 1.2×	784 1.1×	506 1.0×	363 1.0×	137 0.5×	62	2.4k
Qian Xiao	1.3k 0.9×	609 0.8×	952 1.8×	509 1.3×	111 0.4×	111	2.7k
Gangwen Han	1.6k 1.2×	506 0.7×	697 1.3×	645 1.7×	142 0.6×	39	2.9k
Jun Wei	1.3k 1.0×	468 0.6×	655 1.2×	1.1k 3.0×	174 0.7×	73	2.8k
Roland P. Piekorz	1.6k 1.2×	396 0.5×	1.0k 2.0×	1.1k 2.8×	245 1.0×	75	3.4k
Ye Zhou	1.9k 1.5×	961 1.3×	711 1.4×	763 2.0×	131 0.5×	98	3.3k
Min Jin	872 0.7×	325 0.4×	348 0.7×	467 1.2×	145 0.6×	69	2.0k
Judith H. Harmey	1.3k 1.0×	641 0.9×	755 1.4×	464 1.2×	225 0.9×	35	2.7k
Bo Guo	1.4k 1.1×	779 1.1×	699 1.3×	657 1.7×	252 1.0×	86	2.7k
Michaela Schlederer	892 0.7×	323 0.4×	767 1.5×	289 0.8×	139 0.5×	40	1.9k

Countries citing papers authored by Krista La Perle

Since Specialization

Citations

This map shows the geographic impact of Krista La Perle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krista La Perle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krista La Perle more than expected).

Fields of papers citing papers by Krista La Perle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Krista La Perle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krista La Perle. The network helps show where Krista La Perle may publish in the future.

Co-authorship network of co-authors of Krista La Perle

This figure shows the co-authorship network connecting the top 25 collaborators of Krista La Perle. A scholar is included among the top collaborators of Krista La Perle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krista La Perle. Krista La Perle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xue, Miaoge, Olivia Harder, Phylip Chen, et al.. (2020). Stable Attenuation of Human Respiratory Syncytial Virus for Live Vaccines by Deletion and Insertion of Amino Acids in the Hinge Region between the mRNA Capping and Methyltransferase Domains of the Large Polymerase Protein. Journal of Virology. 94(24). 4 indexed citations

Saji, Motoyasu, Caroline S. Kim, Chaojie Wang, et al.. (2020). Akt isoform-specific effects on thyroid cancer development and progression in a murine thyroid cancer model. Scientific Reports. 10(1). 18316–18316. 7 indexed citations

Lorch, Gwendolen, Karthigayini Sivaprakasam, Victoria Zismann, et al.. (2019). Identification of Recurrent Activating HER2 Mutations in Primary Canine Pulmonary Adenocarcinoma. Clinical Cancer Research. 25(19). 5866–5877. 28 indexed citations

Eichler, Tad, Matthew Murtha, Jackie D. Metheny, et al.. (2019). Ribonuclease 7 Shields the Kidney and Bladder from Invasive Uropathogenic Escherichia coli Infection. Journal of the American Society of Nephrology. 30(8). 1385–1397. 30 indexed citations

Foray, Claudia, Anna Tessari, Krista La Perle, et al.. (2018). Genetic ablation of interacting with Spt6 (Iws1) causes early embryonic lethality. PLoS ONE. 13(9). e0201030–e0201030. 7 indexed citations

Perle, Krista La, et al.. (2018). Deletion of Rap1b , but not Rap1a or Epac1 , Reduces Protein Kinase A–Mediated Thyroid Cancer. Thyroid. 28(9). 1153–1161. 13 indexed citations

Comiskey, Daniel F., Aishwarya G. Jacob, Thomas W. Bebee, et al.. (2017). A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo. Oncogene. 37(1). 95–106. 10 indexed citations

Perle, Krista La, Xiaoli Zhang, José I. Piruat, et al.. (2017). Sdhd ablation promotes thyroid tumorigenesis by inducing a stem-like phenotype. Endocrine Related Cancer. 24(11). 579–591. 3 indexed citations

Wang, Chaojie, Motoyasu Saji, Adlina Mohd Yusof, et al.. (2017). RCAN1-4 is a thyroid cancer growth and metastasis suppressor. JCI Insight. 2(5). e90651–e90651. 47 indexed citations

10.

Mishra, Anjali, Krista La Perle, Laura A. Sullivan, et al.. (2016). Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma. Cancer Discovery. 6(9). 986–1005. 75 indexed citations

11.

London, Cheryl A., Heather L. Gardner, Gerald Post, et al.. (2016). KTN0158, a Humanized Anti-KIT Monoclonal Antibody, Demonstrates Biologic Activity against both Normal and Malignant Canine Mast Cells. Clinical Cancer Research. 23(10). 2565–2574. 29 indexed citations

12.

Murrey, Darren, Bartholomew J. Naughton, F. Jason Duncan, et al.. (2014). Feasibility and Safety of Systemic rAAV9-hNAGLU Delivery for Treating MPS IIIB: Toxicology, Bio-distribution and Immunological Assessments in Primates. 776275620–776275620. 6 indexed citations

13.

Murrey, Darren, Bartholomew J. Naughton, F. Jason Duncan, et al.. (2014). Feasibility and Safety of Systemic rAAV9-h NAGLU Delivery for Treating Mucopolysaccharidosis IIIB: Toxicology, Biodistribution, and Immunological Assessments in Primates. PubMed. 25(2). 72–84. 83 indexed citations

14.

Yang, Jennifer, Matthew A. Bill, Gregory Young, et al.. (2014). Novel Small Molecule XPO1/CRM1 Inhibitors Induce Nuclear Accumulation of TP53, Phosphorylated MAPK and Apoptosis in Human Melanoma Cells. PLoS ONE. 9(7). e102983–e102983. 44 indexed citations

15.

Hsu, Shu‐Hao, Bo Wang, Janaiah Kota, et al.. (2012). Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. Journal of Clinical Investigation. 122(8). 2871–2883. 623 indexed citations breakdown →

16.

Bolon, Brad, Suzana S. Couto, Laurence Fiette, & Krista La Perle. (2011). Internet and Print Resources to Facilitate Pathology Analysis When Phenotyping Genetically Engineered Rodents. Veterinary Pathology. 49(1). 224–235. 6 indexed citations

17.

Wang, Hui, Shan K. Naidu, Ravi Rajmohan, et al.. (2010). Allele-specific tumor spectrum in Pten knockin mice. Proceedings of the National Academy of Sciences. 107(11). 5142–5147. 54 indexed citations

18.

Christoforidis, John, et al.. (2010). The Effect of Intravitreal Pegaptanib, Bevacizumab and Ranibizumab on Blood Vessel Formation During Cutaneous Wound Healing in a Rabbit Model. Investigative Ophthalmology & Visual Science. 51(13). 6150–6150.

19.

Santos, Elmer, Raymond Yeh, James Lee, et al.. (2009). Sensitive in vivo imaging of T cells using a membrane-bound Gaussia princeps luciferase. Nature Medicine. 15(3). 338–344. 99 indexed citations

20.

Bouley, Donna M., et al.. (2009). Where's the Mouse Pathology Training?. Veterinary Pathology. 46(6). 1245–1247. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact